{"id":2138,"date":"2024-03-28T10:00:31","date_gmt":"2024-03-28T09:00:31","guid":{"rendered":"https:\/\/tafalgie.fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/"},"modified":"2024-05-30T15:39:27","modified_gmt":"2024-05-30T13:39:27","slug":"defis-100-start-up-dans-lesquelles-investir-en-2024","status":"publish","type":"post","link":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/","title":{"rendered":"Challenges : les 100 start-up dans lesquelles investir en 2024 !"},"content":{"rendered":"\n<div class=\"wp-block-cover alignfull is-light\" style=\"min-height:130px;aspect-ratio:unset;\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-background-dim-100 has-background-dim\" style=\"background-color:#ffffff\"><\/span><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<p class=\"has-text-align-center has-large-font-size\"><\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading text-gradient from-dark-to-light_blue\" style=\"font-style:normal;font-weight:600\">Tafalgie Therapeutics : un antalgique alternatif aux opio\u00efdes<\/h2>\n\n\n\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<figure class=\"wp-block-image alignwide size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1901\" height=\"827\" src=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg\" alt=\"\" class=\"wp-image-774\" srcset=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg 1901w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team-300x131.jpg 300w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team-1024x445.jpg 1024w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team-768x334.jpg 768w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team-1536x668.jpg 1536w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team-700x305.jpg 700w\" sizes=\"auto, (max-width: 1901px) 100vw, 1901px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<p>Tafalgie Therapeutics d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de peptides antalgiques d\u00e9pourvus d&rsquo;effets secondaires invalidants des opio\u00efdes.<\/p>\n\n\n\n<p><strong>Cette start-up fait partie des \u00ab\u00a0100 start-up dans lesquelles investir en 2024\u00a0\u00bb \u00e9dit\u00e9e par le Magazine Challenges.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.challenges.fr\/start-up\/tafalgie-therapeutics-un-anti-douleur-alternatif-aux-opioides_887940\">Lire l&rsquo;article de Challenges ici<\/a><\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tafalgie Therapeutics : un antalgique alternatif aux opio\u00efdes Tafalgie Therapeutics d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de peptides antalgiques d\u00e9pourvus d&rsquo;effets secondaires invalidants des opio\u00efdes. Cette start-up fait partie des \u00ab\u00a0100 start-up dans lesquelles investir en 2024\u00a0\u00bb \u00e9dit\u00e9e par le Magazine Challenges.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[54],"tags":[],"class_list":["post-2138","post","type-post","status-publish","format-standard","hentry","category-couverture-mediatique"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Challenges : les 100 start-up dans lesquelles investir en 2024 ! - Tafalgie Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Challenges : les 100 start-up dans lesquelles investir en 2024 ! - Tafalgie Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Tafalgie Therapeutics : un antalgique alternatif aux opio\u00efdes Tafalgie Therapeutics d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de peptides antalgiques d\u00e9pourvus d&rsquo;effets secondaires invalidants des opio\u00efdes. Cette start-up fait partie des \u00ab\u00a0100 start-up dans lesquelles investir en 2024\u00a0\u00bb \u00e9dit\u00e9e par le Magazine Challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Tafalgie Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-28T09:00:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-30T13:39:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg\" \/>\n<meta name=\"author\" content=\"Tafalgie_client_23\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tafalgie_client_23\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\"},\"author\":{\"name\":\"Tafalgie_client_23\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56\"},\"headline\":\"Challenges : les 100 start-up dans lesquelles investir en 2024 !\",\"datePublished\":\"2024-03-28T09:00:31+00:00\",\"dateModified\":\"2024-05-30T13:39:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\"},\"wordCount\":58,\"publisher\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg\",\"articleSection\":[\"Couverture m\u00e9diatique\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\",\"url\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\",\"name\":\"Challenges : les 100 start-up dans lesquelles investir en 2024 ! - Tafalgie Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg\",\"datePublished\":\"2024-03-28T09:00:31+00:00\",\"dateModified\":\"2024-05-30T13:39:27+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#website\",\"url\":\"https:\/\/tafalgie.fr\/fr\/\",\"name\":\"Tafalgie Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tafalgie.fr\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\",\"name\":\"Tafalgie Therapeutics\",\"url\":\"https:\/\/tafalgie.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png\",\"width\":1024,\"height\":286,\"caption\":\"Tafalgie Therapeutics\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56\",\"name\":\"Tafalgie_client_23\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1778521046\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1778521046\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1778521046\",\"caption\":\"Tafalgie_client_23\"},\"sameAs\":[\"http:\/\/tafalgie.fr\"],\"url\":\"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Challenges : les 100 start-up dans lesquelles investir en 2024 ! - Tafalgie Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"Challenges : les 100 start-up dans lesquelles investir en 2024 ! - Tafalgie Therapeutics","og_description":"Tafalgie Therapeutics : un antalgique alternatif aux opio\u00efdes Tafalgie Therapeutics d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de peptides antalgiques d\u00e9pourvus d&rsquo;effets secondaires invalidants des opio\u00efdes. Cette start-up fait partie des \u00ab\u00a0100 start-up dans lesquelles investir en 2024\u00a0\u00bb \u00e9dit\u00e9e par le Magazine Challenges.","og_url":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/","og_site_name":"Tafalgie Therapeutics","article_published_time":"2024-03-28T09:00:31+00:00","article_modified_time":"2024-05-30T13:39:27+00:00","og_image":[{"url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg","type":"","width":"","height":""}],"author":"Tafalgie_client_23","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Tafalgie_client_23","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#article","isPartOf":{"@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/"},"author":{"name":"Tafalgie_client_23","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56"},"headline":"Challenges : les 100 start-up dans lesquelles investir en 2024 !","datePublished":"2024-03-28T09:00:31+00:00","dateModified":"2024-05-30T13:39:27+00:00","mainEntityOfPage":{"@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/"},"wordCount":58,"publisher":{"@id":"https:\/\/tafalgie.fr\/fr\/#organization"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg","articleSection":["Couverture m\u00e9diatique"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/","url":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/","name":"Challenges : les 100 start-up dans lesquelles investir en 2024 ! - Tafalgie Therapeutics","isPartOf":{"@id":"https:\/\/tafalgie.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg","datePublished":"2024-03-28T09:00:31+00:00","dateModified":"2024-05-30T13:39:27+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/fr\/defis-100-start-up-dans-lesquelles-investir-en-2024\/#primaryimage","url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/02\/tafalgie-therapeutics-team.jpg"},{"@type":"WebSite","@id":"https:\/\/tafalgie.fr\/fr\/#website","url":"https:\/\/tafalgie.fr\/fr\/","name":"Tafalgie Therapeutics","description":"","publisher":{"@id":"https:\/\/tafalgie.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tafalgie.fr\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/tafalgie.fr\/fr\/#organization","name":"Tafalgie Therapeutics","url":"https:\/\/tafalgie.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png","width":1024,"height":286,"caption":"Tafalgie Therapeutics"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56","name":"Tafalgie_client_23","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1778521046","url":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1778521046","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1778521046","caption":"Tafalgie_client_23"},"sameAs":["http:\/\/tafalgie.fr"],"url":"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/"}]}},"_links":{"self":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/comments?post=2138"}],"version-history":[{"count":6,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2138\/revisions"}],"predecessor-version":[{"id":2478,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2138\/revisions\/2478"}],"wp:attachment":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/media?parent=2138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/categories?post=2138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/tags?post=2138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}